The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer

Biochemical and Biophysical Research Communications

Volumn 457, Issue 4, 2015, Pages 706-711

  Nozawa Suzuki, Noriko ^a   Nagasawa, Hideko ^b   Ohnishi, Ken ^c   Morishige, Ken Ichirou ^a,d  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^d GIFU UNIVERSITY   (Japan)

Author keywords

Cancer stem cell; HIF (hypoxia inducible factor); Hypoxia; Stem cell factors

Indexed keywords

3 AMINO 2 QUINOXALINECARBONITRILE 1,4 DIOXIDE; CD133 ANTIGEN; CD44V ANTIGEN; CYTOTOXIC AGENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LIN28 PROTEIN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; SMALL INTERFERING RNA; STEM CELL FACTOR; TIRAPAZAMINE; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; 3-AMINO-2-QUINOXALINECARBONITRILE; AMINE OXIDE; ANTINEOPLASTIC AGENT; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; POU5F1 PROTEIN, HUMAN; QUINOXALINE DERIVATIVE;

ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STEM CELL; CYTOTOXICITY; DRUG EFFECT; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MOLECULARLY TARGETED THERAPY; OVARIAN CANCER CELL LINE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION; TUMOR SPHEROID; CELL HYPOXIA; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARIAN NEOPLASMS; OVARY; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC N-OXIDES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; OVARIAN NEOPLASMS; OVARY; QUINOXALINES;

EID: 84922730618     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.01.053     Document Type: Article

References (22)

1. R.C. Bast, B. Hennessy, and G.B. Mills The biology of ovarian cancer: new opportunities for translation Nat. Rev. Cancer 9 2009 415 428
2. A.D. Steg, K.S. Bevis, A.A. Katre, A. Ziebarth, Z.C. Dobbin, R.D. Alvarez, K. Zhang, M. Conner, and C.N. Landen Stem cell pathways contribute to clinical chemoresistance in ovarian cancer Clin. Cancer Res. 18 2012 869 881
3. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat. Med. 3 1997 730 737
4. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 3983 3988
5. Z. Li, and J.N. Rich Hypoxia and hypoxia inducible factors in cancer stem cell maintenance Curr. Top. Microbiol. Immunol. 345 2010 21 30
6. G.L. Wang, and G.L. Semenza Purification and characterization of hypoxia-inducible factor 1 J. Biol. Chem. 270 1995 1230 1237
7. Z. Li, S. Bao, Q. Wu, H. Wang, C. Eyler, S. Sathornsumetee, Q. Shi, Y. Cao, J. Lathia, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Cancer Cell 15 2009 501 513
8. A. Soeda, M. Park, D. Lee, A. Mintz, A. Androutsellis-Theotokis, R.D. McKay, J. Engh, T. Iwama, T. Kunisada, A.B. Kassam, I.F. Pollack, and D.M. Park Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha Oncogene 28 2009 3949 3959
9. J. Mathieu, Z. Zhang, W. Zhou, A.J. Wang, J.M. Heddleston, C.M. Pinna, A. Hubaud, B. Stadler, M. Choi, M. Bar, M. Tewari, A. Liu, R. Vessella, R. Rostomily, D. Born, M. Horwitz, C. Ware, C.A. Blau, M.A. Cleary, J.N. Rich, and H. Ruohola-Baker HIF induces human embryonic stem cell markers in cancer cells Cancer Res. 71 2011 4640 4652
10. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
11. Y. Yoshida, K. Takahashi, K. Okita, T. Ichisaka, and S. Yamanaka Hypoxia enhances the generation of induced pluripotent stem cells Cell Stem Cell 5 2009 237 241
12. J. Mazumdar, V. Dondeti, and M.C. Simon Hypoxia-inducible factors in stem cells and cancer J. Cell. Mol. Med. 13 2009 4319 4328
13. H. Nagasawa, N. Mikamo, Y. Nakajima, H. Matsumoto, Y. Uto, and H. Hori Antiangiogenic hypoxic cytotoxin TX-402 inhibits hypoxia-inducible factor 1 signaling pathway Anticancer Res. 23 2003 4427 4434
14. T. Baba, P.A. Convery, N. Matsumura, R.S. Whitaker, E. Kondoh, T. Perry, Z. Huang, R.C. Bentley, S. Mori, S. Fujii, J.R. Marks, A. Berchuck, and S.K. Murphy Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells Oncogene 28 2009 209 218
15. M.G. Slomiany, L. Dai, L.B. Tolliver, G.D. Grass, Y. Zeng, and B.P. Toole Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides Clin. Cancer Res. 15 2009 7593 7601
16. C.N. Landen, B. Goodman, A.A. Katre, A.D. Steg, A.M. Nick, R.L. Stone, L.D. Miller, P.V. Mejia, N.B. Jennings, D.M. Gershenson, R.C. Bast, R.L. Coleman, G. Lopez-Berestein, and A.K. Sood Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer Mol. Cancer Ther. 9 2010 3186 3199
17. I.A. Silva, S. Bai, K. McLean, K. Yang, K. Griffith, D. Thomas, C. Ginestier, C. Johnston, A. Kueck, R.K. Reynolds, M.S. Wicha, and R.J. Buckanovich Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Res. 71 2011 3991 4001
18. I. Kryczek, S. Liu, M. Roh, L. Vatan, W. Szeliga, S. Wei, M. Banerjee, Y. Mao, J. Kotarski, M.S. Wicha, R. Liu, and W. Zou Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells Int. J. Cancer 130 2012 29 39
19. J. Nichols, B. Zevnik, K. Anastassiadis, H. Niwa, D. Klewe-Nebenius, I. Chambers, H. Schöler, and A. Smith Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4 Cell 95 1998 379 391
20. K.L. Covello, J. Kehler, H. Yu, J.D. Gordan, A.M. Arsham, C.J. Hu, P.A. Labosky, M.C. Simon, and B. Keith HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth Genes. Dev. 20 2006 557 570
21. K. Ohnishi, T. Tani, S. Bando, N. Kubota, Y. Fujii, O. Hatano, and H. Harada Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids Int. J. Oncol. 45 2014 581 586
22. R.M. Sutherland Cell and environment interactions in tumor microregions: the multicell spheroid model Science 240 1988 177 184